Abstract
The clinical implication of Lipotoxicity in obesity derives primarily from its potential to progress to insulin resistance, endothelial dysfunction and atherosclerosis. Olive oil rich diet decrease accumulation of triglyceride in the liver, improved postprandial triglyceride levels, improve glucose and GLP-1 response in insulin resistant subjects, and up regulate GLUT-2 expression in the liver. The exact molecular mechanism is unknown but, decreasing NFkB activation, decreasing LDL oxidation and improving insulin resistance by less production of inflammatory cytokines (TNF-a, IL-6) and improvement of kinases JNK-mediated phosphorylation of IRS-1 are the principle mechanisms. The beneficial effect of the Mediterranean diet derived from monounsaturated fatty acids (MUFA), mainly from olive oil. In this review we document lipotoxicity in obesity and the benefit of olive oil.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams, J.M., T. Pratipanawatr, R. Berria, et al. 2004. Ceramide content is increased in skeletal muscle from obese insulin resistant humans. Diabetes 53: 25–31.
Alonso, A., V. Ruiz-Gutierrez, and M.A. Martinez-Gonzalez. 2006. Monounsaturated fatty acids, olive oil and blood pressure: Epidemiological, clinical and experimental evidence. Public Health Nutrition 9: 251–257.
Anowski, M., A. Blachnio-Zabielska, T. Hirnle, et al. 2010. Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide. Journal of Lipid Research 51: 74–80.
Bajaj, M., S. Suraamornkul, T. Pratipanawatr, et al. 2003. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes mellitus. Diabetes 52: 1364–1370.
Barrows, B.R., and E.J. Parks. 2006. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. The Journal of Clinical Endocrinology and Metabolism 91: 1446–1452.
Belfort, R., L. Mandarino, S. Kashyap, et al. 2005. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54: 1640–1648.
Belfort, R., S.A. Harrison, K. Brown, et al. 2006. A placebo controlled trial of pioglitazone in patients with non-alcoholic steatohepatitis. New England Journal of Medicine 355: 2297–2307.
Beymer, C., K.V. Kowdley, A. Larson, et al. 2003. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Archives of Surgery 138: 1240–1244.
Boden, Guenther. 2008. Obesity and free fatty acids (FFA) 44. Endocrinology and Metabolism Clinics of North America 37(3): 635–646, viii–ix.
Boden, Guenther, Pengxiang She, Maria Mozzoli, Peter Cheung, and Kiranmai Gumireddy. 2005. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes 54(12): 3458–3465.
Chitturi, S., V. Wong, and G. Farrell. 2011. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. Journal of Gastroenterology and Hepatology 26: 163–172.
Choi, S., and A. Diehl. 2008. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Current Opinion in Lipidology 19: 295–300.
Chokshi, A., K. Drosatos, F.H. Cheema, et al. 2012. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 125: 2844–2853.
Cruz, A.B., D.S. Amatuzio, F. Grande, et al. 1961. Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan diabetic dogs. Circulation Research 9: 39–43.
Cusi, K. 2009. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Current Opinion in Endocrinology, Diabetes, and Obesity 16: 141–149.
Cusi, K., S. Kashyap, A. Gastaldelli, et al. 2007. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. The American Journal of Physiology 292: E1775–E1781.
DeFronzo, R.A. 2010. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53: 1270–1287.
Duff, G.L., and G.C. McMillan. 1949. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. The Journal of Experimental Medicine 89: 611–630.
Ebaid, Geovana M.X., Fábio R.F. Seiva, Katiucha K.H.R. Rocha, Gisele A. Souza, and Ethel L.B. Novelli. 2010. Effects of olive oil and its minor phenolic constituents on obesity-induced cardiac metabolic changes. Nutrition Journal 9: 46.
Esposito, K., R. Marfella, M. Ciotola, et al. 2004. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. Journal of the American Medical Association 292: 1440–1446.
Ferrara, L.A., A.S. Raimondi, L. d’Episcopo, et al. 2000a. Olive oil and reduced need for antihypertensive medications. Archives of Internal Medicine 160: 837–842.
Fitó, M., R. Estruch , J. Salas-Salvadó, et al.; PREDIMED Study Investigators. 2014. Effect of the Mediterranean diet on heart failure biomarkers: A randomized sample from the PREDIMED trial. European Journal of Heart Failure 16(5):543–550.
Fraser, A., R. Abel, D.A. Lawlor, D. Fraser, and A. Elhayany. 2008. A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: Results of a quasi-randomized controlled trial. Diabetologia 51: 1616–1622.
Freedman, D. 2011. Obesity—United States, 1988-2008. MMWR Surveillance Summaries 60(Suppl): 73–77.
García-Rúa, V., M.F. Otero, P.V. Lear, et al. 2012. Increased expression of fatty-acid and calcium metabolism genes in failing human heart. PLoS One 7: e37505.
Gentile, C., and M. Pagliassotti. 2008a. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry 19: 567–576.
Gilani, A.H., A.U. Khan, A.J. Shah, et al. 2005. Blood pressure lowering effect of olive is mediated through calcium channel blockade. International Journal of Food Sciences and Nutrition 56: 613–620.
Gill, C.I., A. Boyd, E. McDermott, et al. 2005. Potential anti-cancer effects of virgin olive oil phenols on colorectal carcinogenesis models in vitro. International Journal of Cancer 117: 1–7.
Halbirk, M., H. Norrelund, N. Moller, et al. 2010. Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. American Journal of Physiology. Heart and Circulatory Physiology 299: H1220–H1225.
Harrison, S. 2006. Liver disease in patients with diabetes mellitus. Journal of Clinical Gastroenterology 40: 68–76.
Haus, J.M., S.R. Kashyap, T. Kasumov, et al. 2009. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58: 337–343.
Herrera, M.D., C. Perez-Guerrero, E. Marhuenda, and V. Ruiz-Gutierrez. 2001. Effects of dietary oleic-rich oils (virgin olive and high-oleic-acid sunflower) on vascular reactivity in Wistar-Kyoto and spontaneously hypertensive rats. The British Journal of Nutrition 86: 349–357.81.
Heydrick, S.J., N.B. Ruderman, T.G. Kurowski, et al. 1991. Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle. Altered protein kinase C activity and possible link to insulin resistance. Diabetes 40: 1707–1711.
Holland, W.L., B.T. Bikman, L.P. Wang, et al. 2011. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. The Journal of Clinical Investigation 121: 1858–1870.
Hu, F.B., R.M. van Dam, and S. Liu. 2001. Diet and risk of type II diabetes: The role of types of fat and carbohydrate. Diabetologia 44: 805–817.
Itani, S.I., N.B. Ruderman, F. Schmieder, et al. 2002. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and I kappa B-alpha. Diabetes 51: 2005–2011.
Jiang, Z.Y., Y.W. Lin, A. Clemont, et al. 1999. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. The Journal of Clinical Investigation 104: 447–457.
Kashyap, S., R. Belfort, A. Gastaldelli, et al. 2003. A sustained increase in plasma free fatty acids impairs insulin secretion in non-diabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52: 2461–2474.
Keys, A., A. Menotti, M.J. Karvonen, et al. 1986. The diet and 15-year death rate in the Seven Countries Study. American Journal of Epidemiology 124: 903–915.
Kim, J.K., J.J. Fillmore, Y. Chen, et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 98: 7522–7527.
Kim, J.A., M. Montagnani, K.K. Koh, and M.J. Quon. 2006. Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms. Circulation 113: 1888–1904.
Knoops, K.T., L.C. de Groot, D. Kromhout, A.E. Perrin, O. Moreiras-Varela, A. Menotti, and W.A. van Staveren. 2004. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women the HALE project. Journal of the American Medical Association 292: 1433–1439.
Knopp, R.H., B. Retzlaff, C. Walden, et al. 2000. One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proceedings of the Society for Experimental Biology and Medicine 225: 191–199.
Labbé, S.M., T. Grenier-Larouche, E. Croteau, et al. 2011. Organ-specific dietary fatty acid uptake in humans using positron emission tomography coupled to computed tomography. American Journal of Physiology. Endocrinology and Metabolism 300: E445–E453.
Lefterova, M.I., and M.A. Lazar. 2009. New developments in adipogenesis. Trends in Endocrinology and Metabolism 20: 107–114.
Lumeng, C.N., and A.R. Saltiel. 2011. Inflammatory links between obesity and metabolic disease. The Journal of Clinical Investigation 121: 2111–2117.
Maeno, Y., Q. Li, K. Park, et al. 2012. Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K). The Journal of Biological Chemistry 287: 4518–4530.
Marfella, R., C. Di Filippo, M. Portoghese, et al. 2009. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. Journal of Lipid Research 50: 2314–2323.
Mayerson, A.B., R.S. Hundal, S. Dufour, et al. 2002. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51: 797–802.
Miyazaki, Y., A. Mahankali, M. Matsuda, et al. 2002. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. The Journal of Clinical Endocrinology and Metabolism 87: 2784–2791.
Musso, G., R. Gambino, M. Cassader, et al. 2010. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine 43: 617–649.
Newmark, H.L. 1997. Squalene, olive oil, and cancer risk: A review and hypothesis. Cancer Epidemiology, Biomarkers & Prevention 6: 1101–1103.
O’Connor, R.D., J. Xu, G.A. Ewald, et al. 2011. Intramyocardial triglyceride quantification by magnetic resonance spectroscopy: In vivo and ex vivo correlation in human subjects. Magnetic Resonance in Medicine 65: 1234–1238.
Okanoue, T., A. Umemura, K. Yasui, et al. 2011. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. Journal of Gastroenterology and Hepatology 26: 153–162.
Ortiz-Lopez, C., R. Lomonaco, B. Orsak, et al. 2012. Prevalence of prediabetes and diabetes and metabolic profile of patients with non-alcoholic fatty liver disease (NAFLD). Diabetes Care 35: 1–6.
Owen, R.W., A. Giacosa, W.E. Hull, R. Haubner, G. Würtele, B. Spiegelhalder, and H. Bartsch. 2000. Olive-oil consumption and health: The possible role of antioxidants. The Lancet Oncology 1: 107–112.
Paniagua, J.A., A. Gallego de la Sacristana, I. Romero, et al. 2007. Monounsaturated fat-rich diet prevents centralbody fat distribution and decreases postprandial expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 30: 1717–1723.
Perona, J.S., R. Cabello-Moruno, and V. Ruiz-Gutierrez. 2006. The role of virgin olive oil components in the modulation of endothelial function. The Journal of Nutritional Biochemistry 17: 429–445.
Peters, A., J. Barendregt, F. Willekens, et al. 2003. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Annals of Internal Medicine 138: 1138–1145.
Porepa, L., J.G. Ray, P. Sanchez-Romeu, et al. 2010. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. Canadian Medical Association Journal 182: E526–E531.
Psaltopoulou, T., A. Naska, P. Orfanos, et al. 2004. Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. The American Journal of Clinical Nutrition 80: 1012–1018.
Rask-Madsen, C., Q. Li, B. Freund, et al. 2010. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metabolism 11: 379–389.
Ratziu, V., S. Caldwell, and B.A. Neuschwander-Tetri. 2010. Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues. Hepatology 52: 2206–2215.
Relas, H., H. Gylling, and T.A. Miettinen. 2000. Dietary squalene increases cholesterol synthesis measured with serum non-cholesterol sterols after a single oral dose in humans. Atherosclerosis 152: 377–383.
Rodríguez-Rejón, A.I., I. Castro-Quezada, C. Ruano-Rodríguez, M.D. Ruiz-López, A. Sánchez-Villegas, et al. 2014. Effect of a Mediterranean diet intervention on dietary glycemic load and dietary glycemic index: the PREDIMED study. Journal of Nutrition and Metabolism 2014: 985373.
Ros, E. 2003. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. The American Journal of Clinical Nutrition 78: 617S–625S.
Ruiz-Gutierrez, V., F.J. Muriana, A. Guerrero, et al. 1997. Role of dietary oleic acid from different sources on fatty acid composition of erythrocyte membrane and blood pressure in healthy subjects. The Journal of Nutritional Biochemistry 8: 689–695.
Schrauwen-Hinderling, V.B., M.K. Hesselink, R. Meex, et al. 2010. Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content. The Journal of Clinical Endocrinology and Metabolism 95: 1932–1938.
Schwartz, E.A., and P.D. Reaven. 2006. Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinology and Metabolism Clinics of North America 35: 525–549.
Schwartz, E.A., W.Y. Zhang, S.K. Karnik, et al. 2010. Nutrient modification of the innate immune response: A novel mechanism by which saturated fatty acids greatly amplifies monocyte inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 802–808.
Stamler, J., R. Pick, and L.N. Katz. 1960. Effect of insulin in the induction and regression of atherosclerosis in the chick. Circulation Research 8: 572–526.
Starley, B.Q., C.J. Calcagno, and S.A. Harrison. 2010. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 51: 1820–1832.
Strandberg, T.E., R.S. Tilvis, and T.A. Miettinen. 1990. Metabolic variables of cholesterol during squalene feeding in humans: Comparison with cholestyramine treatment. Journal of Lipid Research 31: 1637–1643.
Thomsen, C., O. Rasmussen, T. Lousen, J.J. Holst, S. Fenselau, J. Schrezenmeir, and K. Hermansen. 1999. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. The American Journal of Clinical Nutrition 69: 1135–1143.
Trichopoulou, A., T. Costacou, C. Bamia, and D. Trichopoulos. 2003. Adherence to a Mediterranean diet and survival in a Greek population. The New England Journal of Medicine 348: 2599–2608.
Unger, R.H., G.O. Clark, P.E. Scherer, et al. 1801. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta 2010: 209–214.
Vernon, G., A. Baranova, and Z.M. Younossi. 2011. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics 34: 274–285.
Wende, A.R., and E.D. Abel. 1801. Lipotoxicity in the heart. Biochimica et Biophysica Acta 2010: 311–319.
Wende, Adam R., J. David Symons, and E. Dale Abel. 2012a. Mechanisms of lipotoxicity in the cardiovascular system. Current Hypertension Reports 14(6): 517–531.
Wende, A.R., J.D. Symons, E.D. Abel. 2012b. Mechanisms of lipotoxicity in the cardiovascular system. Current Hypertension Reports 14(6): 517–531. Waterman, Emily, and Brian Lockwood. 2007. Active components and clinical applications of olive oil. Alternative Medicine Review 12(4).
Winhofer, Y., M. KršKršák, D. Janković, et al. 2012. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects. Diabetes 61: 1210–1216.
Wong, V., W. Chu, G. Wong, et al. 2012. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: A population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61: 409–415.
Yu, C.L., Y. Chen, G.W. Cline, et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 2-kinase activity in muscle. The Journal of Biological Chemistry 277: 50230–50236.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Elias, S., Wisam, S., Luai, A., Massad, B., Nimer, A. (2017). Lipotoxicity in Obesity: Benefit of Olive Oil. In: Engin, A., Engin, A. (eds) Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology, vol 960. Springer, Cham. https://doi.org/10.1007/978-3-319-48382-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-48382-5_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48380-1
Online ISBN: 978-3-319-48382-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)